Literature DB >> 35994165

Progress in Osteochondral Regeneration with Engineering Strategies.

Hui Gao1,2, Qian Pan1,2, Weiqiang Dong1, Yongchang Yao3,4.   

Abstract

Osteoarthritis, the main cause of disability worldwide, involves not only cartilage injury but also subchondral bone injury, which brings challenges to clinical repair. Tissue engineering strategies provide a promising solution to this degenerative disease. Articular cartilage connects to subchondral bone through the osteochondral interfacial tissue, which has a complex anatomical architecture, distinct cell distribution and unique biomechanical properties. Forming a continuous and stable osteochondral interface between cartilage tissue and subchondral bone is challenging. Thus, successful osteochondral regeneration with engineering strategies requires intricately coordinated interplay between cells, materials, biological factors, and physical/chemical factors. This review provides an overview of the anatomical composition, microstructure, and biomechanical properties of the osteochondral interface. Additionally, the latest research on the progress related to osteochondral regeneration is reviewed, especially discussing the fabrication of biomimetic scaffolds and the regulation of biological factors for osteochondral defects.
© 2022. The Author(s) under exclusive licence to Biomedical Engineering Society.

Entities:  

Keywords:  Articular cartilage; Gradients; Osteoarthritis; Osteochondral interface; Tissue engineering

Mesh:

Substances:

Year:  2022        PMID: 35994165     DOI: 10.1007/s10439-022-03060-6

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   4.219


  69 in total

1.  Sustained Release SDF-1α/TGF-β1-Loaded Silk Fibroin-Porous Gelatin Scaffold Promotes Cartilage Repair.

Authors:  Yuanfeng Chen; Tingting Wu; Shusen Huang; Chun-Wai Wade Suen; Xin Cheng; Jieruo Li; Huige Hou; Guorong She; Huantian Zhang; Huajun Wang; Xiaofei Zheng; Zhengang Zha
Journal:  ACS Appl Mater Interfaces       Date:  2019-04-15       Impact factor: 9.229

Review 2.  Osteoarthritis: an update with relevance for clinical practice.

Authors:  Johannes W J Bijlsma; Francis Berenbaum; Floris P J G Lafeber
Journal:  Lancet       Date:  2011-06-18       Impact factor: 79.321

Review 3.  Emerging techniques in stratified designs and continuous gradients for tissue engineering of interfaces.

Authors:  Nathan H Dormer; Cory J Berkland; Michael S Detamore
Journal:  Ann Biomed Eng       Date:  2010-04-22       Impact factor: 3.934

4.  Communication between paired chondrocytes in the superficial zone of articular cartilage.

Authors:  Simon S Chi; Jerome B Rattner; John R Matyas
Journal:  J Anat       Date:  2004-11       Impact factor: 2.610

5.  Continuous gradient scaffolds for rapid screening of cell-material interactions and interfacial tissue regeneration.

Authors:  Brennan M Bailey; Lindsay N Nail; Melissa A Grunlan
Journal:  Acta Biomater       Date:  2013-05-22       Impact factor: 8.947

6.  Scaffold-free bioprinted osteogenic and chondrogenic systems to model osteochondral physiology.

Authors:  Erick K Breathwaite; Jessica R Weaver; Angela C Murchison; Michelle L Treadwell; Justin J Odanga; Jung Bok Lee
Journal:  Biomed Mater       Date:  2019-10-03       Impact factor: 3.715

Review 7.  Bioactive scaffolds for osteochondral regeneration.

Authors:  Cuijun Deng; Jiang Chang; Chengtie Wu
Journal:  J Orthop Translat       Date:  2018-12-26       Impact factor: 5.191

8.  Dual delivery of stem cells and insulin-like growth factor-1 in coacervate-embedded composite hydrogels for enhanced cartilage regeneration in osteochondral defects.

Authors:  Hyeran Cho; Junhyung Kim; Sungjun Kim; Yun Chan Jung; Yadong Wang; Byung-Jae Kang; Kyobum Kim
Journal:  J Control Release       Date:  2020-08-05       Impact factor: 9.776

9.  Bioactive Scaffolds for Regeneration of Cartilage and Subchondral Bone Interface.

Authors:  Cuijun Deng; Huiying Zhu; Jiayi Li; Chun Feng; Qingqiang Yao; Liming Wang; Jiang Chang; Chengtie Wu
Journal:  Theranostics       Date:  2018-02-15       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.